Insider Sale: Chief Legal Officer of $HIMS (HIMS) Sells 30,000 Shares
Insider Sale: Chief Legal Officer of $HIMS (HIMS) Sells 30,000 Shares
Soleil Boughton, the Chief Legal Officer of $HIMS ($HIMS), sold 30,000 shares of the company on 01-06-2025. We received data on the trade from a recent SEC filing. This was a sale of approximately 15.0% of their shares. Following this trade, they now own 169,803 shares of $HIMS stock.
索莱尔·博顿,$HIMS ($HIMS) 的首席法律官于2025年1月6日出售了30,000股该公司的股票。我们从近期的SEC备案中获得了该交易的数据。这次出售大约占他们持股的15.0%。在这次交易后,他们现在持有169,803股$HIMS的股票。
$HIMS Insider Trading Activity
$HIMS内幕交易活动
$HIMS insiders have traded $HIMS stock on the open market 125 times in the past 6 months. Of those trades, 2 have been purchases and 123 have been sales.
$HIMS的内幕人士在过去6个月中在公开市场上交易了$HIMS的股票125次。其中,2次是购买,123次是出售。
Here's a breakdown of recent trading of $HIMS stock by insiders over the last 6 months:
以下是过去6个月内内幕人士对$HIMS股票的最近交易汇总:
- SOLEIL BOUGHTON (Chief Legal Officer) has traded it 13 times. They made 0 purchases and 13 sales, selling 294,652 shares.
- MICHAEL CHI (Chief Commercial Officer) has traded it 18 times. They made 0 purchases and 18 sales, selling 257,854 shares.
- OLUYEMI OKUPE (Chief Financial Officer) has traded it 32 times. They made 0 purchases and 32 sales, selling 595,080 shares.
- ANDREW DUDUM (Chief Executive Officer) has traded it 27 times. They made 0 purchases and 27 sales, selling 1,617,515 shares.
- IRENE BECKLUND (PAO) has traded it 8 times. They made 0 purchases and 8 sales, selling 22,860 shares.
- MELISSA BAIRD (Chief Operating Officer) has traded it 21 times. They made 0 purchases and 21 sales, selling 306,285 shares.
- ANJA MANUEL has traded it 2 times. They made 2 purchases, buying 5,000 shares and 0 sales.
- DAVID B WELLS sold 40,000 shares.
- PATRICK HARRISON CARROLL (Chief Medical Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 19,707 shares.
- CHRISTIANE PENDARVIS sold 7,000 shares.
- 索莱尔·博顿(首席法律官)进行过13次交易。他们没有购买,卖出了294,652股。
- 迈克尔·奇(首席商业官)进行过18次交易。他们没有购买,卖出了257,854股。
- 奥卢耶米·奥库佩(首席财务官)进行过32次交易。他们没有购买,卖出了595,080股。
- 安德鲁·杜杜姆(首席执行官)进行过27次交易。他们没有购买,卖出了1,617,515股。
- IRENE BECKLUND(PAO)交易了8次。他们没有进行购买,而是进行了8次出售,售出了22,860股。
- 梅丽莎·贝尔德(首席运营官)交易了21次。他们没有购买,进行了21次销售,总共出售了306,285股。
- 安佳·曼纽尔已交易2次。他们进行了2次购买,购买了5,000股,且没有销售。
- 大卫·b·威尔斯卖出了40,000股。
- 帕特里克·哈里森·卡罗尔(首席医疗官)已交易2次。他们没有购买,进行了2次销售,出售19,707股。
- 克里斯蒂安·佩恩达维斯卖出了7,000股。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要跟踪内部交易,请查看Quiver Quantitative的内部交易特斯拉-仪表。
$HIMS Hedge Fund Activity
$HIMS对冲基金活动
We have seen 165 institutional investors add shares of $HIMS stock to their portfolio, and 131 decrease their positions in their most recent quarter.
我们看到165家机构投资者在最近一个季度增加了$HIMS股票的持股,而131家则减少了他们的持股。
Here are some of the largest recent moves:
以下是最近的一些重大变动:
- FMR LLC removed 3,808,320 shares (-99.2%) from their portfolio in Q3 2024
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 2,070,438 shares (+2340.6%) to their portfolio in Q3 2024
- VANGUARD GROUP INC added 1,765,240 shares (+10.7%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 1,735,117 shares (-88.0%) from their portfolio in Q3 2024
- BALYASNY ASSET MANAGEMENT L.P. added 1,700,144 shares (+inf%) to their portfolio in Q3 2024
- AMERIPRISE FINANCIAL INC added 1,494,982 shares (+894.2%) to their portfolio in Q3 2024
- SQUAREPOINT OPS LLC added 1,264,196 shares (+inf%) to their portfolio in Q3 2024
- FMR LLC在2024年第三季度从其投资组合中移除了3,808,320股(-99.2%)。
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP在2024年第三季度向其投资组合中增加了2,070,438股(+2340.6%)。
- 先锋集团在2024年第三季度向其投资组合中增加了1,765,240股(+10.7%)。
- MILLENNIUM管理公司在2024年第三季度从其投资组合中移除了1,735,117股(-88.0%)。
- BALYASNY资产管理L.P. 在2024年第三季度增加了1,700,144股(+inf%)到他们的投资组合中。
- AMERIPRISE FINANCIAL INC在2024年第三季度向其投资组合中增加了1,494,982股(+894.2%)。
- SQUAREPOINt OPS LLC在2024年第三季度增加了1,264,196股(+inf%)到他们的投资组合中
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要跟踪对冲基金的股票投资组合,请查看Quiver Quantitative的机构持有情况仪表。
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
本文不是金融建议。有关更多信息,请参阅Quiver Quantitative的免责声明。